Updated REMS for Rosiglitazone-containing Medicines

Published Online: Friday, October 21, 2011
Follow Pharmacy_Times:
Listen as Catherine Chew, a pharmacist in the FDA’s Division of Drug Information, describes the restrictions for prescribing and using rosiglitazone-containing medicines, including type 2 diabetes medications Avandia, Avandamet, and Avandaryl.

Click here to access the podcast.
Related Articles
The FDA today approved dulaglutide (Trulicity), a once-weekly injectable therapy indicated to improve blood sugar control in adults with type 2 diabetes.
Research conducted by CVS Health supported its move to discontinue sales of tobacco products.
Latest Issues
$auto_registration$